Blog

Our passion for the cannabis industry.

Epileptic Georgia high school student can’t take his legal CBD medicine on campus

WARNER ROBINS, Ga. — Each day about lunchtime at Warner Robins High School, 17-year-old CJ Harris must leave campus to take his medicine. His dad, Curtis Harris, drives to school, gets CJ out of class, and the two ride around the block or sometimes head home. CJ draws some cannabis oil in a syringe, squirts it under his tongue and waits for it to dissolve. He’s been taking the medicine every six hours for the past four months for epilepsy. “I haven’t had a seizure since,” the high school football player said. The oil, derived from the cannabis plant, wasn’t a problem for administrators at First Presbyterian Day School, a private school in Macon. But the rules are different at public schools, the Harrises learned during a recent transfer process to Houston County. “I told them about it, you know, ‘He takes (the) oil for his seizures … , and that’s when they went into a panic, like, ‘We don’t know what to do about this,’” Curtis Harris said of Houston County school officials. “They called the head state nurse, and the head state nurse told him that he can’t even have it on campus.” CJ is the first medical marijuana patient at a Houston County school since state Rep. Allen Peake of Macon introduced a law in 2015 that established a state medical marijuana registry that is limited to people with specific diseases. Read more: Epileptic Georgia high school student can’t take his legal CBD medicine on...

Here’s what just changed in Washington state marijuana laws

A week ago, Washington Governor Jay Inslee signed an omnibus marijuana bill, containing many changes to the regulations put in place in 2013, after Washington voters legalized recreational marijuana sales in 2012. Senate Bill 5131 passed the Senate on April 20 with a vote of 44-5, and the House that same day, 63-33. What developments does this marijuana mega-bill contain? Here’s our wrap-up of the major changes that could affect how Washingtonians and visitors experience legal weed in The Evergreen State. (All of these regulations go into effect July 23, 2017) Read more: Here’s what just changed in Washington state marijuana...

Vermont governor to announce decision on marijuana legalization Wednesday

MONTPELIER, Vt. — Vermont Gov. Phil Scott says he still hasn’t decided whether he will allow the state to legalize the recreational use of marijuana, but he won’t allow the bill to become law without his signature. UPDATE: Why Vermont gov vetoed legalization bill Scott’s office said Tuesday that the Republican governor will agree to sign the bill into law or veto it. Scott, a Republican, plans to announce Wednesday his decision on the marijuana legalization bill that was passed by the Legislature earlier this money. Read more: Vermont governor to announce decision on marijuana legalization...

Rhode Island judge rules in favor of medical marijuana patient in discrimination case

PROVIDENCE, R.I. — A judge has ruled against a Rhode Island textile company accused of discriminating against a woman when she was denied an internship because she uses medical marijuana to treat migraine headaches. The Superior Court judge’s decision released Tuesday found that the Westerly-based Darlington Fabrics Corp. had violated the state’s Hawkins-Slater Medical Marijuana Act, which prevents discrimination against card-carrying medical marijuana users. The complaint said Christine Callaghan, who was a graduate student at the University of Rhode Island, negotiated a paid internship with Darlington Fabrics in 2014 but lost it after disclosing she held a medical marijuana card. Read more: Rhode Island judge rules in favor of medical marijuana patient in discrimination...

Report: Medical marijuana could poach more than $4B from pharma sales annually

If the United States legalized medical marijuana for conditions such as chronic pain, anxiety and seizures, cannabis could siphon more than $4 billion annually from the nation’s pharmaceutical industry, a new study hypothesizes. The report expected to be released Wednesday by New Frontier Data, a provider of data and analytics to cannabis businesses, is intended to show how cannabis could disrupt pharmaceutical sales in nine key treatment areas. “Any opportunity for alternatives that could result in reduced pharmaceutical drug use might present a compelling point of discussion from a public policy standpoint,” said John Kagia, executive vice president of industry analytics for the Washington, D.C.-based New Frontier. With the backdrop of opioid use concerns and the simmering debates on health care reform and marijuana legalization, Kagia and fellow analysts sought to explore the idea of pharmaceutical substitution — people eschewing prescription drugs and using medical marijuana to treat certain ailments. Read more: Report: Medical marijuana could poach more than $4B from pharma sales...
Integration With Tellermate

Integration With Tellermate

Viridian Sciences is happy to announce integration with Tellermate’s Intelligent Cash Counting system! The need to count cash is universal however, the management processes are diverse and varied. For this reason, we offer a range of electronic cash counters from simple stand-alone units to feature rich, multi-till connected solutions, all designed to help you reduce cash loss, save time and gather cash counting information....